Key result
NASH-promoting diet drives progressive NAFLD in mice, causing severe steatosis in 75% versus controls.
Why the study?
There are no approved pharmacological treatments for NAFLD, necessitating mechanistic studies using diet-induced preclinical models to develop prevention or therapeutic strategies.
Does a NASH-promoting diet induce progressive histopathological, biochemical, transcriptomic, and microbiome changes in adult male mice compared to a control diet?
Does a NASH-promoting diet induce progressive histopathological, biochemical, transcriptomic, and microbiome changes in adult male mice compared to a control diet?
Absolute Event Rate: 75% vs 0%
A diet high in fat, fructose, and cholesterol induces progressive NAFLD/NASH in mice, with early immune and microbiome changes and late xenobiotic metabolism changes, supporting its use as a preclinical model.
Supports this diet as a murine NASH model; leaves open human translation and therapeutic testing.
Non-alcoholic fatty liver disease (NAFLD), and resultant non-alcoholic steatohepatitis (NASH), incidence and prevalence are rising globally due to increasing rates of obesity and diabetes. Currently, there are no approved pharmacological treatments for NAFLD, highlighting a need for additional mechanistic studies to develop prevention and/or therapeutic strategies. Diet-induced preclinical models of NAFLD can be used to examine the dynamic changes that occur during NAFLD development and progression throughout the lifespan. To date, most studies utilizing such models have focused exclusively on terminal time points and have likely missed critical early and late changes that are important for NAFLD progression (i.e, worsening). We performed a longitudinal analysis of histopathological, biochemical, transcriptomic, and microbiome changes that occurred in adult male mice fed either a control diet or a NASH-promoting diet (high in fat, fructose, and cholesterol) for up to 30 weeks. We observed progressive development of NAFLD in mice fed the NASH diet compared to the control diet. Differential expression of immune-related genes was observed at an early stage of diet-induced NAFLD development (10 weeks) and persisted into the later stages of the disease (20 and 30 weeks). Differential expression of xenobiotic metabolism related genes was observed at the late stage of diet-induced NAFLD development (30 weeks). Microbiome analysis revealed an increased abundance of Bacteroides at an early stage (10 weeks) that persisted into the later stages of the disease (20 and 30 weeks). These data provide insight into the progressive changes that occur during NAFLD/NASH development and progression in the context of a typical Western diet. Furthermore, these data are consistent with what has been reported in patients with NAFLD/NASH, supporting the preclinical use of this diet-induced model for development of strategies to prevent or treat the disease.
No takes yet. Share an insight, caveat, or question.
Saenz et al. (2023) studied Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). NASH-promoting diet vs. Control diet was evaluated on Severe steatosis (>60% fat accumulation) at 30 weeks. Mice fed a NASH-promoting diet for 30 weeks exhibited progressive NAFLD development, with 75% showing severe steatosis and 63% showing fibrosis compared to 0% in control mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: